CBIZ (NYSE: CBZ), a national provider of financial, insurance, and advisory services, recently announced its Q4 2025 earnings, revealing a mixed performance. While revenue increased by 17.9% year-over-year to $542.7 million, it fell short of analyst estimates of $578 million. The company reported a non-GAAP loss per share of $0.70, also missing the consensus estimate of a $0.66 loss. This marks a notable downturn, especially considering the company's historical growth and recent acquisition of Marcum LLP.
The market has reacted negatively to the earnings miss. CBIZ's stock price has declined, reaching a 52-week low of $25.44. This decline reflects a one-year decrease of approximately 64%, highlighting the challenges the company has faced in maintaining its value. Despite the recent struggles, some analysts suggest the stock may be undervalued, with InvestingPro data indicating a fair value of $43.56. Management has also been actively buying back shares, signaling confidence in the company's long-term prospects.
CBIZ provides a range of services, including accounting, tax, benefits, insurance brokerage, and advisory services to small and mid-sized businesses across the United States and Canada. The company operates through three main practice groups: Financial Services, Benefits and Insurance Services, and National Practices. Despite the disappointing Q4 results, CBIZ's full-year 2025 revenue reached $2.71 billion, a 52% increase compared to the previous year. However, the company's guidance for 2026 suggests a slowdown in revenue growth, with expectations of only 2-5%.
Looking ahead, investors will be closely monitoring CBIZ's ability to stabilize its growth and capitalize on its strong cash flow and recurring revenue. The company's next earnings report, scheduled for April 23, 2026, will provide further insights into its performance and future outlook. While challenges remain, CBIZ's diversified service offerings and strategic acquisitions position it to navigate the evolving business landscape.
